Table 2 Marginal effect expenses estimates in patients with arterial hypertension according level physical active in a crude analyse.
Marginal effects (US$) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Consultation | Laboratory tests | Medication | Total primary care | Total sec. and terc. care | ||||||
Estim. (S.E.) | [95% CI] | Estim. (S.E.) | [95% CI] | Estim. (S.E.) | [95% CI] | Estim. (S.E.) | [95% CI] | Estim. (S.E.) | [95% CI] | |
NOR + ACTIVE (reference) (n = 31) | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
NOR + IA (n = 69) | 5.9 (4.4) | -2.7; 14.6 | -2.8 (2.2) | -7.2; 1.5 | 8.2 (4.9) | -1.4; 17.9 | 11.3 (8.0) | -4.4; 27.1 | 19.7 (178.9) | -330.8; 370.4 |
AH + ACTIVE (n = 51) | 17.5** (6.0) | 5.6; 29.3 | 2.4 (2.9) | -3.3; 8.2 | 20.0** (7.5) | 5.2; 34.8 | 40.0** (11.4) | 17.5; 62.4 | 155.6 (209.5) | -255.1; 566.4 |
AH + IA (n = 156) | 23.5** (4.7) | 14..3; 32.8 | 0.4 (2.2) | -4.0; 4.9 | 43.0** (7.4) | 28.4; 57.5 | 67.0** (9.6) | 48.1; 85.9 | 289.0 (179.1) | -62.1; 640.2 |